PDS Biotechnology

$3.75 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About PDS Biotechnology

PDS Biotechnology Corp operates as a clinical-stage biotechnology company. The Company develops immuno-oncology therapies to treat various early and late stage cancers including head and neck, prostate, breast, cervical, and anal cancers. PDS Biotechnology serves patients worldwide.

Stock Analysis

last close $3.7
1-mo return -26.6%
3-mo return -41.9%
avg daily vol. 1.6M
52-week high 17.85
52-week low 2.91
market cap. $95M
forward pe -
annual div. -
roe -55.7%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 20.7%

Subscribe now for daily local and international financial news